FDA Building
Pharma

FDA clears ImmunityBio’s Anktiva expansion after back-and-forth

To expand Anktiva’s label, the FDA adopted a new approach to how it evaluates treatments for BCG-unresponsive NMIBC.
Angus Liu Oct 14, 2026 5:17pm
sale transaction MA deal changing hands money money changing hands

Ultragenyx cashes in a pair of FDA review vouchers for $413M

Oct 14, 2026 4:19pm
United Therapeutics HQ

United lines up $380M settlement from Liquidia in patent feud

Oct 14, 2026 10:33am
Illustration connected puzzle pieces with the acronym MA

Galderma targets medical skincare growth with $1.5B Zo buyout

Oct 14, 2026 10:31am
Hiking gear with a forest in the background

AbbVie slots in ‘Time For Treks’ with CLL community walk

Oct 14, 2026 10:05am
Magnifying glass with pills on blue

Regulatory tracker: FDA accepts Ebvallo resubmission, PFP's 3rd

Oct 14, 2026 9:45am
More News

FTC alleges Martin Shkreli violated pharma ban with stock trades

Oct 14, 2026 8:40am

Soon-Shiong backs rounds for Prolific Machines, Multiply Labs

Oct 14, 2026 7:52am

Sanofi dodges fine over alleged disparagement of CSL flu vaccine

Oct 14, 2026 7:18am
Fierce Biotech

GSK to lay off 1,200 roles in Belgium under cost-saving program

Oct 14, 2026 6:37am